microdose glp-1 cost Protocol Microdosing Tirzepatide Program | No

While Im excited that patients may soon have more options, enthusiasm should not blind us to the risks

With the knowledge of miRNA profiles, we can personalize treatment plans to ensure that each patient gets the most out of it with the least amount of danger

Kim JY, Lee H, Oh KS, Kweon S, Jeon Ocheol, Byun Y, et al

Losing muscle slows your metabolism, reduces strength, and makes long-term weight maintenance harder

A weight loss integrative provider addresses medical and lifestyle factors affecting weight

Combining the therapeutic approaches of GLP-1 agonists (which target extrahepatic mechanisms for metabolic disorders) with resmetirom (which target intrahepatic mechanisms for MASH and liver fibrosis) seems like a promising strategy for addressing fat accumulation, inflammation, and fibrosis associated with MASH